Last edition
News about "Dyadic enters collaboration with Syngene "
Dyadic enters collaboration with Syngene to develop Covid-19 vaccine
Dyadic International, Inc. (Dyadic), a global biotechnology company, has entered into a collaboration with Syngene International Limited (Syngene), an integrated research, development, and manufacturing services company, to develop a Covid-19 vaccine candidate that can protect against the emerging variants of concern
Dyadic Enters Collaboration With Syngene | 27/05/2021 | By Darshana | 239
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members